Hayek Kallen Investment Management Novo Nordisk A S Transaction History

Hayek Kallen Investment Management

$272 Million
Q1 2025

A detailed history of Hayek Kallen Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Hayek Kallen Investment Management holds 50,996 shares of NVO stock, worth $3.76 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

50,996

Previous 55,220 7.65%

Holding current value

$3.76 Million

Previous $4.75 Million 25.45%

% of portfolio

1.3%

Previous 1.73%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$69.3 - $90.95 $292,723 - $384,172	-4,224 Reduced 7.65%	50,996 $3.54 Million
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $113,900 - $160,853	-1,340 Reduced 2.37%	55,220 $4.75 Million
Q3 2024 Oct 15, 2024	SELL	$119.07 - $145.42 $160,744 - $196,316	-1,350 Reduced 2.33%	56,560 $6.74 Million
Q2 2024 Jul 18, 2024	SELL	$122.71 - $146.91 $88,964 - $106,509	-725 Reduced 1.24%	57,910 $8.27 Million
Q1 2024 May 03, 2024	SELL	$102.11 - $135.92 $190,230 - $253,218	-1,863 Reduced 3.08%	58,635 $7.53 Million
Q4 2023 Feb 08, 2024	SELL	$87.78 - $105.45 $418,096 - $502,258	-4,763 Reduced 7.3%	60,498 $6.26 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $2.9 Million - $6.37 Million	31,913 Added 95.7%	65,261 $5.94 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $37,435 - $41,436	240 Added 0.72%	33,348 $5.4 Million
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $240,594 - $289,316	-1,818 Reduced 5.21%	33,108 $5.27 Million
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $61,530 - $81,198	-600 Reduced 1.69%	34,926 $4.73 Million
Q3 2022 Oct 19, 2022	SELL	$95.28 - $116.93 $16,674 - $20,462	-175 Reduced 0.49%	35,526 $3.54 Million
Q2 2022 Aug 11, 2022	SELL	$103.24 - $121.81 $64,525 - $76,131	-625 Reduced 1.72%	35,701 $3.98 Million
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $67,497 - $81,591	-725 Reduced 1.96%	36,326 $4.03 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $93,483 - $114,153	-975 Reduced 2.56%	37,051 $4.15 Million
Q3 2021 Oct 06, 2021	SELL	$84.42 - $106.62 $149,338 - $188,610	-1,769 Reduced 4.45%	38,026 $3.65 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $13,396 - $16,782	-198 Reduced 0.5%	39,795 $3.33 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $23,246 - $25,630	-365 Reduced 0.9%	39,993 $2.78 Million
Q2 2020 Sep 10, 2020	SELL	$58.54 - $67.94 $21,893 - $25,409	-374 Reduced 0.92%	40,358 $2.64 Million
Q1 2020 Apr 22, 2020	SELL	$49.46 - $64.78 $40,309 - $52,795	-815 Reduced 1.96%	40,732 $2.45 Million
Q4 2019 Feb 13, 2020	SELL	$49.86 - $58.26 $2,991 - $3,495	-60 Reduced 0.14%	41,547 $2.41 Million
Q3 2019 Nov 05, 2019	SELL	$47.54 - $53.43 $20,109 - $22,600	-423 Reduced 1.01%	41,607 $2.15 Million
Q2 2019 Jul 17, 2019	SELL	$46.79 - $52.47 $10,621 - $11,910	-227 Reduced 0.54%	42,030 $2.15 Million
Q1 2019 May 09, 2019	SELL	$46.36 - $52.63 $14,835 - $16,841	-320 Reduced 0.75%	42,257 $2.21 Million
Q4 2018 Jan 16, 2019	BUY	$41.54 - $47.25 $2,575 - $2,929	62 Added 0.15%	42,577 $1.96 Million
Q3 2018 Nov 09, 2018	SELL	$46.76 - $51.24 $38,904 - $42,631	-832 Reduced 1.92%	42,515 $2 Million
Q3 2018 Nov 09, 2018	BUY	$46.76 - $51.24 $48,957 - $53,648	1,047 Added 2.48%	43,347 $2.14 Million
Q2 2018 Aug 03, 2018	SELL	$44.29 - $50.42 $46,371 - $52,789	-1,047 Reduced 2.42%	42,300 $1.95 Million
Q1 2018 May 10, 2018	SELL	$48.49 - $58.14 $73,947 - $88,663	-1,525 Reduced 3.4%	43,347 $2.14 Million
Q4 2017 Feb 08, 2018	SELL	$47.53 - $53.73 $23,765 - $26,865	-500 Reduced 1.1%	44,872 $2.41 Million
Q3 2017 Oct 25, 2017	BUY	$41.15 - $49.22 $1.87 Million - $2.23 Million	45,372	45,372 $2.19 Million

Others Institutions Holding NVO

# of Institutions

1,769

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $167B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Account

Hayek Kallen Investment Management Novo Nordisk A S Transaction History